echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > 【Pediatric Anesthesia】The incidence of nausea and vomiting after pediatric surgery is high, which needs attention!

    【Pediatric Anesthesia】The incidence of nausea and vomiting after pediatric surgery is high, which needs attention!

    • Last Update: 2022-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit


    Autumn has its own gentleness that is neither hot nor cold, in this season you can experience the most drizzling rain and the gentlest wind, of course, you can feel the beauty and heart of the fallen leaves falling on the ground, stepping on them and creaking

    Postoperative nausea and vomiting is the main cause of dissatisfaction in adult patients after anesthesia and surgery, and the incidence of postoperative vomiting (POV) is even higher
    in children than in adults.
    It is difficult to diagnose nausea in younger children and is likely to be
    Effective management is not only important in terms of humane care, but the length of stay in PACU is largely determined by PONOV
    After tonsillar adenoidectomy, every vomiting that occurs causes a delay of 28 minutes, which is the
    main reason for
    unexpected hospital admissions after outpatient surgery.

    In 2014, the PONOV Management Consensus Guidelines were introduced and used as an evidence-based tool for clinicians, which focus on identifying at-risk patients, what are the risk factors for PONV/POV, recommendations for prevention, and the most effective treatment principles
    Prophylactic treatment of POV in children usually requires pharmacological
    intervention, but this can be costly or associated with adverse effects
    Therefore, the ideal target is those
    who are at particular risk of POV.
    Although risk factors are similar in children to those in adults, there are some differences
    POV is rare in children under 2 years of age, but increases with age

    Long and increasing, it does not decrease
    until after puberty.
    A study in children under 14 years of age pointed out that PONC increased sharply at the age of 3, and the incidence increased at a rate of 0.
    8% for each additional year of age
    There appears to be no sex difference in prepubertal children, but a history
    of PONOV or motion sickness may be a risk factor
    in parents or siblings.
    Certain surgical procedures have also been associated with a high incidence of POV in children, such as adenotonsillectomy, orchiopexy, penile surgery, hernia repair, and especially strabismus.

    The revised PONM consensus guidelines include a simplified risk score to determine the degree of risk for POV in children, and the degree of risk depends on the number of the following risk factors: (1) surgery time≥ 30 minutes; (2) Age≥ 3 years old; (3) strabismus surgery; (4) Family history of
    POV or PONV.
    the number of risk factors increases, so does the risk of POV, with one risk factor representing 10% risk and four risk factors representing 70% risk
    It is important to note that this risk assessment does not include tonsillectomy (with or without adenoidectomy) as a major risk factor for POV, but many consider tonsillectomy to be an important cause of


    After identifying children at risk of POV, the next step is to adopt strategies that reduce underlying risk factors, such as advocating the use of propofol or subhypnotic doses of propofol
    in total intravenous anesthesia (TIVA).
    Although it has not been proven in the pediatric population, for adults at high risk of PONV, inhalation anesthetics
    and N2O are recommended against them, and continuous area blocking techniques
    should be used.
    Although this approach is rarely used in children, it is critical
    to implement multimodal analgesia aimed at reducing the need for opioids.
    In addition, the Cochrane database of systematic reviews has disproved the idea that
    the use of NSAIDs in tonsillectomy leads to increased postoperative bleeding.
    Therefore, the use of NSAIDs after such procedures should be encouraged to reduce the need for
    Finally, it is actually possible to insist that your child drink water before leaving the room

    Can increase the incidence of PONM, but appropriate intraoperative hydration has been shown to reduce its incidence

    Prophylactic pharmacotherapy can be either monotherapy or a combination, but the recommended prophylactic antiemetics for pediatric patients are 5-HT3 receptor antagonists such as ondansetron, dolasetron, granisetron, torcisetron, and ramosetron
    Since the publication of the first guidelines, ondansetron (0.
    1mg/kg, maximum 4mg) has been approved for children aged 1 month, followed by granisetron (40μg
    /kg) and tophasetron (0.
    /kg) as treatment options
    Ramosetron reduces the incidence of PONV to 9% in children undergoing strabismus surgery, but it has not been listed as a treatment option
    for children.
    Because drugs such as 5-HT3
    receptor antagonists are more effective than nausea in preventing vomiting, they are currently the first-line prevention
    of PONV in children.
    However, the latest data on the pharmacokinetics of ondansetron indicate
    a decrease
    in the clearance of the drug in children under 6 months of age.
    This is partly due to immaturity of cytochrome P-enzymes, so it is currently recommended that children under 4 months of age should be monitored
    more closely after receiving ondansetron.
    In addition, 5-HT3
    receptor antagonists can prolong the QT interval, and caution should be exercised when using large doses to avoid inducing arrhythmias

    Other treatments for the prevention of PONOV include dexamethasone (0.
    /kg), fluperidol (0.
    075mg/kg to 1.
    ), diphenhydramine (0.
    and perphenazine (0.

    The revised guidelines reduce the upper dose limit of dexamethasone from 8 mg to 5 mg to reduce concerns about
    adverse effects such as hypoglycemia, delayed wound healing, and wound infection.
    In addition, dexamethasone has also been associated with tumor lysis syndrome, a potentially fatal metabolic disorder due to the destruction of tumor cells, and the use of dexamethasone may mask indicators used to guide tumor treatment, so
    its use must be discussed
    before administering the drug to newly diagnosed cancer patients.
    That said, dexamethasone is a highly effective antiemetic drug, and the timing of administration is a key factor
    in successful prevention.
    For example, dexamethasone should be used early in anesthesia, while ondansetron has been shown to be more effective

    before surgery.

    The 2014 consensus guidelines recommend that children with moderate or high risk of POV should receive a combination of 2~3 different classes of prophylactic drugs
    This differs from the recommendation for adult patients, who recommend that only "high-risk" adults should receive combination therapy
    The recommended combinations in the revised consensus guidelines for children are ondansetron
    05 mg/kg) versus dexamethasone (0.
    015 mgkg), ondansetron (0.
    1 mg/kg) and fluperidol (0.
    015 mg/kg), or torcisetron (0.
    1 mg/kg) and dexamethasone (0.
    5 mg/kg).

    。 All of these combinations require intraoperative administration, and specific medications, doses, and timing of administration need to be communicated during handover in order to treat a variety of flare-ups of PONV/POV
    with these data.

    Guidelines also give recommendations for PONV/POV that occurs in PACUs or when preventive treatment fails, including that antiemetics should be used from different classes rather than those used for prophylaxis
    Despite the extrapyramidal adverse effects of haloperidol, it can be used in
    pediatric patients
    who are hospitalized and do not respond to all other treatments.
    Because it can cause
    the QT interval to be prolonged, the FDA issued a "black box" warning
    for haloperidol in 2001.
    The risk of heart effects of halopereridol is no higher than that of other antiemetic drugs being used in doses prescribed in the United States, but this possibility can still significantly reduce a physician's willingness to
    Due to reports of cases of respiratory depression and death from the perioperative combination of promethazine and opioids, the US FDA has also issued a boxed warning against promethazine in children
    under 2 years of age.

    Recently, the neurokinin-1 receptor antagonist aprepitant has been approved for the treatment of chemotherapy-induced nausea and vomiting
    in children older than 12 years.
    Although there are no data on children yet, numerous studies have reported
    on its use in adults for the preventive treatment of PONV.
    Researchers have conducted some studies
    on non-drug therapies in children.
    Although aromatherapy is effective in adults, studies in children have shown that it does not confer significant clinical benefits

    Acupuncture has been successfully used to prevent POV in children undergoing strabismus, dental surgery, and tonsillectomy, but others have found that the effectiveness of this technique in children is unclear

    Due to the variety of options and the fact that the incidence of POV in children is higher than in adults, there is a need for a better understanding of POV in children and age-appropriate treatment to reduce this adverse effect


    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.